These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. pH-sensitive nano-systems for drug delivery in cancer therapy. Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541 [TBL] [Abstract][Full Text] [Related]
6. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers. Moritz M; Geszke-Moritz M Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624 [TBL] [Abstract][Full Text] [Related]
7. Evaluating Nanomedicines: Obstacles and Advancements. Swierczewska M; Crist RM; McNeil SE Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088 [TBL] [Abstract][Full Text] [Related]
8. Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications. Frimpong RA; Hilt JZ Nanomedicine (Lond); 2010 Nov; 5(9):1401-14. PubMed ID: 21128722 [TBL] [Abstract][Full Text] [Related]
9. Recent Insights into Effective Nanomaterials and Biomacromolecules Conjugation in Advanced Drug Targeting. Azandaryani AH; Kashanian S; Jamshidnejad-Tosaramandani T Curr Pharm Biotechnol; 2019; 20(7):526-541. PubMed ID: 31038063 [TBL] [Abstract][Full Text] [Related]
10. Nano/Microcarriers in Drug Delivery: Moving the Timeline to Contemporary. Nikezić AV; Novaković JG Curr Med Chem; 2023; 30(26):2996-3023. PubMed ID: 36017848 [TBL] [Abstract][Full Text] [Related]
11. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery. Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075 [TBL] [Abstract][Full Text] [Related]
12. [Targeted nanomedicine in diagnostics and therapy of neurological diseases]. Bertalan F; László B; Attila V Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015 [TBL] [Abstract][Full Text] [Related]
13. Nanocarriers & drug delivery: rational design and applications. Garcia-Fuentes M; Gonzalez-Díaz H; Csaba N Curr Top Med Chem; 2014; 14(9):1095-6. PubMed ID: 24678712 [No Abstract] [Full Text] [Related]
14. Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine. Pearce AK; O'Reilly RK Bioconjug Chem; 2019 Sep; 30(9):2300-2311. PubMed ID: 31441642 [TBL] [Abstract][Full Text] [Related]
15. Nanoscale drug delivery for targeted chemotherapy. Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607 [TBL] [Abstract][Full Text] [Related]
16. Silica-based matrices: State of the art and new perspectives for therapeutic drug delivery. Andreani T; Silva AM; Souto EB Biotechnol Appl Biochem; 2015; 62(6):754-64. PubMed ID: 25471460 [TBL] [Abstract][Full Text] [Related]
17. Nano-carriers for drug routeing - towards a new era. Lakkireddy HR; Bazile DV J Drug Target; 2019; 27(5-6):525-541. PubMed ID: 30570365 [TBL] [Abstract][Full Text] [Related]
18. Limits and challenges in using transport inhibitors to characterize how nano-sized drug carriers enter cells. Francia V; Reker-Smit C; Boel G; Salvati A Nanomedicine (Lond); 2019 Jun; 14(12):1533-1549. PubMed ID: 31208280 [No Abstract] [Full Text] [Related]
19. Surface engineered multifunctional nano-systems for localised drug delivery against thyroid cancer: A review of current practices. Zhang Y; Tang N; Zhou H; Zhu Y Biomed Pharmacother; 2024 Jul; 176():116840. PubMed ID: 38820975 [TBL] [Abstract][Full Text] [Related]
20. Cancer nanomedicine: from targeted delivery to combination therapy. Xu X; Ho W; Zhang X; Bertrand N; Farokhzad O Trends Mol Med; 2015 Apr; 21(4):223-32. PubMed ID: 25656384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]